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ABSTRACT
Monoubiquitination of the Fanconi anemia comple-
mentation group D2 (FANCD2) protein by the FA
core ubiquitin ligase complex is the central event
in the FA pathway. FANCA and FANCG play major
roles in the nuclear localization of the FA core com-
plex. Mutations of these two genes are the most fre-
quently observed genetic alterations in FA patients,
and most point mutations in FANCA are clustered in
the C-terminal domain (CTD). To understand the ba-
sis of the FA-associated FANCA mutations, we deter-
mined the cryo-electron microscopy (EM) structures
of Xenopus laevis FANCA alone at 3.35 Å and 3.46
Å resolution and two distinct FANCA–FANCG com-
plexes at 4.59 and 4.84 Å resolution, respectively. The
FANCA CTD adopts an arc-shaped solenoid structure
that forms a pseudo-symmetric dimer through its
outer surface. FA- and cancer-associated point mu-
tations are widely distributed over the CTD. The two
different complex structures capture independent in-
teractions of FANCG with either FANCA C-terminal
HEAT repeats, or the N-terminal region. We show
that mutations that disturb either of these two inter-
actions prevent the nuclear localization of FANCA,
thereby leading to an FA pathway defect. The struc-
ture provides insights into the function of FANCA
CTD, and provides a framework for understanding
FA- and cancer-associated mutations.
INTRODUCTION
Fanconi anemia (FA) is a genetic disorder characterized by
cellular hypersensitivity toward DNA interstrand crosslink-
ing (ICL) reagents, bone marrow failure, developmental de-
fects and cancer susceptibility (1–3). The FA pathway is
triggered by stalled DNA replication forks at ICLs, lead-
ing to the activation of the FA core ubiquitin ligase com-
plex (4,5). The FA complementation (FANC) core complex
is imported into the nucleus and catalyzes the addition of
a single ubiquitin to each chain of the FANCI–FANCD2
(ID) complex. Ubiquitinated ID localizes to chromatin,
leading to the recruitment of nucleases that unhook the
ICLs in preparation for repair by translesion synthesis and
homologous recombination (6–12).
The FA core complex comprises seven FANC proteins
and two FA-associated proteins (FAAPs) that form a net-
work of three functional modules (6,13–14). A dimer of
the FANCB-FANCL-FAAP100 (BL100) hetero-trimer at
the center of the core complex provides the catalytic ubiq-
uitin ligase activity and forms a scaffold for other sub-
complexes (13–15). The FANCC-FANCE-FANCF (CEF)
complex anchors on the BL100 complex and transfers the
ID substrate to the FANCL ligase (16–20). The BL100
and CEF subcomplexes are sufficient to monoubiquitinate
FANCD2 in vitro (13,14). However, the FANCA–FANCG–
FAAP20 (AG20) subcomplex is essential for monoubiqui-
tination of FANCD2 in vivo (6).
FANCA and FANCG are critical for the localization of
the FANC core complex (21,22). FANCA contains a bi-
partite nuclear localization signal (NLS) motif in the N-
terminal region, which is recognized by FANCG, a critical
feature for nuclear accumulation of the FANC core proteins
(23,24). Other FANC core components are also required for
nuclear import of FANCA, suggesting that the three func-
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tional modules of the FANC core cooperate to achieve nu-
clear localization (25–27). Interestingly, FANCA mutants
lacking the C-terminal domain (CTD) were able to form a
complex with FANCG, but failed to be imported into the
nucleus, suggesting that the CTD of FANCA is crucial for
localization of the FANC core complex (24). Most FA- and
cancer-associated point mutations in FANCA are clustered
at the CTD, supporting the importance of this structural
component for FANCA function (http://www2.rockefeller.
edu/fanconi/ and https://cancer.sanger.ac.uk/cosmic/gene/
analysis?ln=FANCA). The CTD binds to single-strand
DNA (ssDNA) and ssRNA, and it has been suggested that
the CTD contributes to the ssDNA annealing (SSA) and
exchange (SSE) activities of FANCA (28,29). Dimerization
of FANCA is important for these activities (28). To investi-
gate the roles of FANCA and FANCG in the FA pathway,
and to better understand the FA- and cancer-associated
mutations, we determined several cryo-electron microscopy
(EM) structures of Xenopus laevis FANCA: the FANCA
CTD alone at 3.35 Å and 3.46 Å resolution and the two dis-
tinct FANCA–FANCG complexes at 4.59 and 4.84 Å reso-
lution, respectively (Figure 1; Supplementary Figures S1-2
and Table S1).
The two structures of FANCA alone show that the
FANCA CTD folds into an arc-shaped solenoid struc-
ture, which forms a pseudo-symmetric dimer. The struc-
ture allows for the establishment of a correlation in the
patient-derived mutations, the nuclear localization, stabil-
ity and the DNA binding in FANCA. The FANCA CTD
structure reveals a long path decorated with a cluster of
positively charged residues, providing a rationale for how
FANCA might interact with DNA. The structure of the
FANCA complexed with FANCG (FANCA–FANCG) re-
veals that the C-terminal HEAT (Huntingtin, elongation
factor 3 (EF3), protein phosphatase 2A (PP2A), and the
yeast kinase TOR1) repeats of FANCA binds to the helical
repeats at the C-terminal end of FANCG (Figure 1B and
D). In another complex structure (FANCA’–FANCG’), the
N-terminal domain (NTD) of the full-length FANCA inter-
acts with FANCG (Figure 1C and D). Both binding inter-
faces are required for the nuclear localization of FANCA.
We present a model of the FANCA and FANCG com-
plex as a hetero-tetramer, in which the FANCG–FANCA–
FANCA’–FANCG’ forms a curved chain. Our structures
provide insights into the function of the FANCA CTD and
a framework for understanding how the FA- and cancer-
associated missense mutations affect the activity of the FA
pathway.
MATERIALS AND METHODS
Expression and purification of the FANCA–FANCG com-
plex
Genes encoding Xenopus laevis (Xl) FANCA and FANCG
were synthesized with codon-optimization for expression
in insect cells (Gene Universal). Genes encoding full-
length FANCA and FANCG were amplified by polymerase
chain reaction (PCR) and separately cloned pFastBac vec-
tors (EcoRI–NotI for FANCA and EcoRI–HindIII for
FANCG). The resulting FANCA and FANCG constructs
were fused with a Strep tag (WSHPQFEK) and a 2 × Flag
tag, respectively, at their N-terminal end. Baculoviruses har-
boring FANCA and FANCG constructs were generated in
Spodoptera frugiperda Sf9 cells using the Bac-to-Bac sys-
tem (Invitrogen). For expression of the FANCA–FANCG
complex, High-Five cells were co-infected with both bac-
uloviruses at a multiplicity of infection (MOI) of 3.5 and
harvested after 60 h. Cell pellets were resuspended in ly-
sis buffer (25 mM Tris–HCl pH 8.0, 0.5 M NaCl, 5 mM
dithiothreitol (DTT), 10% glycerol, 1 mM phenylmethylsul-
fonyl fluoride (PMSF), Roche protease inhibitor cocktail)
and sonicated. The lysate was cleared by ultracentrifugation
at 40 000 g and the supernatant was applied to StrepTactin
XT resin (IBA Lifesciences). After washing, the bound pro-
tein was eluted with Strep elution buffer (25 mM Tris–HCl
pH 8.0, 0.5 M NaCl, 5 mM DTT, 10% glycerol and 50 mM
biotin) and subsequently loaded onto a Mono Q 10/100
GL column for ion-exchange chromatography (GE Health-
care). The column was washed carefully and eluted over a
0−600 mM NaCl linear gradient. Peak fractions were col-
lected, concentrated, and stored at −80◦C.
Cryo-EM sample preparation and data collection
The FANCA–FANCG complex was freshly prepared for
cryo-EM grids immediately after size exclusion chromatog-
raphy, which was performed using a Superdex 200 10/300
GL column equilibrated with 25 mM Tris–HCl pH 8.0,
0.2 M NaCl and 2 mM DTT (GE Healthcare). Peak frac-
tions were collected, mixed with 0.003% n-dodecyl--D-
maltopyranoside (DDM) and 3 l of the complex (0.8
mg/ml) was applied to a glow-discharged holey carbon grid
(C-flat 1.2/1.3 Au 400-mesh grid; EMS). Grids were plunge-
frozen in liquid ethane using a Vitrobot Mark IV (Thermo
Fisher Scientific) operating at 4◦C with 100% humidity and
blotted for 8.5 s with the blot force 2 setting. Images were
acquired using an FEI Titan Krios transmission electron
microscope operated at 300 kV and equipped with an FEI
Falcon III direct electron detector (at Korea Basic Science
Institute) at a nominal magnification of 47 000 ×, corre-
sponding to a pixel size of 1.4 Å at the specimen level.
Two datasets were collected comprising 2176 (dataset I)
and 1903 (dataset II) micrographs. Both datasets were col-
lected with a pixel size of 1.4 Å and a total electron dose of
30 e−/Å2. A defocus of −1.5 to −2.5 m was employed, 30
frames were collected in 74.4 s (2.48 s/frame) and the total
electron dose was 30 electrons per Å2 distributed over 30
frames (Supplementary Table S1).
Data processing
Movie frames were aligned and dose-weighted using Mo-
tionCor2 (30). The resulting motion-corrected sums were
used to estimate the contrast transfer function (CTF) us-
ing CTFFIND4 (31). Micrographs with low estimated res-
olution were eliminated. Initially, ∼4000 particles were
manually picked using cryoSPARC v.2 to generate two-
dimensional (2D) models for reference-based particle pick-
ing (32). Manually picked particles were subjected to sev-
eral rounds of unsupervised 2D classification. A total of 1
523 728 particles were automatically picked from 3635 mi-
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Figure 1. Three classes of the overall structures of the FANCA–FANCG complex. (A) Cryo-EM map of the FANCA CTD dimer at an average resolution
of 3.35 Å. Each FANCA molecule is shown in orange (FANCA) and green (FANCA’). The arc-shaped CTD is divided into the N-terminal half (arcN)
and the C-terminal half (arcC). (B) Cryo-EM map (gray) of the FANCA CTD dimer complexed with a FANCG (purple) molecule at 4.6 Å. FANCG CTD
packs at the C-terminal end of FANCA. Orientation of the CTD dimer is same as that in (A). (C) Cryo-EM map (gray) of the FANCA and FANCG
complex at 4.84 Å. FANCG’ is bound at the FANCA’ NTD (yellow). (D) Overall scheme of the subdomain composition in FANCA and FANCA’. Each
subdomain is painted with same colors as in (A) to (E). (E) Two views of the 3.46 Å structure of the FANCA CTD dimer. Left, A 2-fold rotation axis is
along the horizontal axis. Each HEAT repeat consists of the HA and HB helices that forms inner and outer surfaces, respectively. The central axes (along
each H8B helix) of two solenoids are arranged in ∼80◦. Right, View orthogonal to the left view looking down the 2-fold axis which is along the H8B
helices from the two FANCA molecules. The CTD structure is divided into the N-terminal helical subdomain (H1 to linker helix), arcN (H3 to HM1) and
arcC (H7 to H14) subdomains. The helical subdomain of FANCA’ is shown in cyan. The arcN and arcC subdomains of FANCA CTD are colored in light
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tracted with a box size of 256 pixels (Supplementary Fig-
ure S1). Contaminants and false-positive particles were re-
moved by rounds of 2D classification, and 501 654 parti-
cles were retained for further processing. This particle set
was subjected to ab initio reconstruction and 3D hetero-
geneous refinement into four classes with C1 symmetry.
Both two classes revealed a clear arc-shaped 3D volume
and most particles were selected for 3D homogeneous re-
finement. The arc-shaped 3D volume contains residues 631–
1402 of FANCA (see below). The combined classes yielded
306,460 particles and were further improved by perform-
ing local motion correction and patch CTF extraction. Sub-
sequent homogeneous refinement and non-uniform refine-
ment of polished particles resulted in a map with a global
resolution of 3.35 Å according to a Fourier shell correla-
tion (FSC) criterion of 0.143. One of the selected classes
showing additional small density corresponding to helical
subdomain (residues 530–619) of FANCA was subjected to
homogeneous refinement followed by non-uniform refine-
ment which resulted in a resolution of 3.46 Å after par-
ticle polishing. The final map was sharpened using nega-
tive B-factors automatically determined by cryoSPARC v.2.
The other two classes, one with elongated density between
the two arcN subdomains (Because FANCA CTD forms an
arc-shaped structure, we refer the N-terminal half (residues
631–900) and the C-terminal half (residues 901–1402) of
FANCA CTD to arcN and arcC, respectively, throughout
the text) and the other with superhelical density beneath
the arc-shaped volume, were exported to RELION-3 (33)
and subjected to 3D refinement. The resulting two classes
with different shaped molecules were further classified by
focussed 3D classification with a mask covering additional
density not including the arc-shaped volume. Each of the
two classes of particles were divided into five and six subsets,
respectively. In each class, one subset with different confor-
mation from the others was excluded. The remaining sub-
sets were combined for 3D refinement and post-processing,
which resulted the two complex structures in resolutions of
4.59 Å and 4.84 Å, respectively, corresponding to an FSC
value of 0.143 after particle polishing (Supplementary Fig-
ure S1). The maps were sharpened using negative B-factors
automatically determined by RELION-3.
Model building
An atomic model was built from the 3.35 Å EM map, re-
vealing a helix-rich molecule with a solenoid shape. The
map was of good quality and clearly revealed bulky side
chains and good connectivity for the main chains, which
allowed us to assign most of the side chains. Overall, the
C-terminal half of FANCA clearly fits into the EM map.
Initially, FANCA was built de novo from a poly-Ala model,
which was manually improved using COOT (34). Sequence
assignment was guided by bulky Tyr, Phe and Trp residues,
and small Gly, Ser and Val residues. There was no clear
density for the N-terminal 20 residues or the C-terminal
20 residues, hence we could not assign side chains for these
residues. The structure was subjected to real-space refine-
ment using PHENIX 1.14 with secondary structures and
geometry restraints (35). Iteration of model building and re-
finement yielded the final model that includes residues 631–
1402. The refined model has a MolProbity (36) score of 1.84
and a Clash score of 4.17 at 3.8 Å resolution with excellent
geometry (Supplementary Table S1). A model for the heli-
cal subdomain (residues 530–619) of one FANCA molecule
was built on the 3.46 Å EM map. The regions modeled as
poly-alanine chains or omitted are summarized in Supple-
mentary Table S3
In other models, the NTD of FANCA (FANCA’) and
FANCG bound to FANCA CTD (FANCA) were built as
poly-alanine chains in COOT. The NTD of FANCA and
FANCG bound to FANCA CTD were assigned with 310
and 319 alanine residues, respectively. Because the EM map
of FANCG bound to the FANCA NTD was not well-
resolved, we docked a FANCG model from the Passmore’s
group (PDB ID: 6SRI) into the EM map in Chimera using
‘fit in map’ tool (15,37). However, the EM map of FANCG
CTD bound to FANCA CTD was more clearly resolved
and we were able to independently build a model in ab initio.
FANCA cross-linking assay
The purified FANCA and FANCG hetero-tetramer was di-
luted to 0.2 mg/ml with reaction buffer (25 mM Tris–HCl
pH 7.0, 0.2 M NaCl and 5% glycerol), resulting a final con-
centration of 0.38 mM DTT. Bismaleimidoethane (BMOE;
Thermo Fisher Scientific) was dissolved in dimethylsulfox-
ide (DMSO) immediately before use and added at the indi-
cated concentrations. After a 5 min incubation at room tem-
perature, the reaction was quenched by addition of 70 mM
cysteine and further incubated for 10 min. Samples from
stopped reactions were subjected to sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS-PAGE). For
H2O2 crosslinking reactions, DTT in the purified FANCA
and FANCG complex was completely removed by dialysis
against 25 mM Tris–HCl pH 7.0, 0.2 M NaCl and 10% glyc-
erol. The dialyzed sample was incubated with H2O2 at room
temperature. After a 3 h incubation, samples were directly
separated by SDS-PAGE then subjected to Coomassie Bril-
liant Blue staining.
Yeast two-hybrid assay
Yeast two-hybrid assays were performed by Panbionet
(http://panbionet.com). The synthesized genes encoding
human FANCA and FANCG were amplified by PCR and
cloned into both pGBKT7 and pGADT7 vectors (Clon-
tech). All the FANCA mutations used in this study were in-
troduced by PCR-based site-directed mutagenesis and veri-
fied by DNA sequencing. Plasmids were transformed into
the AH109 yeast strain, which expresses HIS3 reporters.
Transformants were separately plated on SD-LeuTrp and
SD- LeuTrpHis medium containing 10 mM 3-amino-1,2,3-
triazole (3-AT), a competitive inhibitor of the HIS3 protein
(His3p).
Immunofluorescence microscopy
The gene encoding human FANCA was amplified and
cloned into the pFlag-CMV-2 vector (a generous gift from
Dr Kyong Tai Kim at POSTECH) using EcoRI and XbaI.
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tag at its N-terminal end. The mutations were introduced
in the same way mentioned above. The FANCA-deficient
U2OS cell line was a generous gift from Dr Yanbin Zhang
at University of Miami (28,38). Transfections for Transient
expression of FANCA WT and mutant constructs were per-
formed using Lipofectamine 3000 transfection reagent ac-
cording to the manufacturer’s protocol. Transfected cells
were treated with either H2O (Mock) or 1uM mitomycin
C (MMC) for 24 h and then washed with phosphate-
buffered saline (PBS, pH 7.4). Cells were fixed with 4%
paraformaldehyde in PBS, followed by washing four times
with 0.1% triton X-100 in PBS for 5 min each on a shaker.
Next, the cells were incubated for 1 h in blocking buffer
(3% BSA in PBS), followed by incubation in blocking buffer
containing anti-FANCA antibody (1:250, Rabbit, Bethyl,
A301–980A) or anti-Flag antibody (Cell Signaling, 8146S)
for 2 h at room temperature. Cells were washed four times
with 0.1% triton X-100 in PBS for 5 min each on a shaker
and incubated for 1 h in blocking buffer containing goat
anti-mouse secondary antibody conjugated to Alex488 (In-
vitrogen). Cells were again washed with washing buffer. Cell
nuclei were stained with a mounting medium containing
4′,6-diamidino-2-pheylindole (DAPI) (Vector Laboratories,
CA, USA). For analysis of FANCA localization, images
were taken using a ZEISS Axio observer seven microscopy.
To determine percentages of cells with different staining
patterns, 100 cells were scored in two independent experi-
ments.
RESULTS
Structures of the FANCA and FANCG complex
Size exclusion chromatography analysis showed that
FANCA and FANCG form a stable complex with a
molecular weight of ∼500 kDa that is predicted to be a
hetero-tetramer (Supplementary Figure S1). Single-particle
cryo-EM analysis revealed four classes of FANCA–
FANCG complex structures––two classes for FANCA
alone and two classes for the complex. One of the major
classes corresponds to the dimer of the CTD of FANCA
(Figure 1A and E; Supplementary Figures S1 and 2).
The side chains of FANCA are well-defined in the 3.35
Å EM density map, and clusters of bulky hydrophobic
side chains unambiguously guided the tracing of residues
631–1370 (helix H3A to helix H13B, Supplementary
Figures S2-3 and Table S3). The model is supported by
in vitro analyses showing that FANCA dimerizes through
its CTD, and FANCA CTD can be cross-linked through
the proximal Cys residues at the dimeric interface (28,39)
(Supplementary Figure S4). Two additional helices are also
clearly visible at the C-terminal ends (H14A and H14B)
of FANCA CTD. However, the side chains of the residues
for these helices are not clearly defined. The N-terminal
helical subdomain (residues 530–619) is visible only in
one FANCA CTD protomer (FANCA’) in the 3.46 Å
EM density map (Supplementary Figure S1 and Table
S3). FANCA recognizes FANCG through two different
modes. In one structural class of the complex, one of the
protomers (orange color) in a FANCA dimer packs against
the tetratricopeptide repeat (TPR) region of FANCG
(purple) through its C-terminal HEAT repeats (Figure 1B
and Supplementary Figure S1). We refer this complex as
the FANCA–FANCG complex throughout the text. In
the second class of the FANCA–FANCG complex, the
NTD of FANCA (yellow) formed with multiple HEAT
repeats is packed at the inner surface of the FANCA dimer,
through which FANCG (purple) is recruited (Figure 1C
and Supplementary Figure S1). We define this complex as
the FANCA’–FANCG’ complex.
Overall structure of FANCA
The FANCA CTD folds into an arc-shaped -solenoid
structure (light orange and orange color) (Figure 1A, D
and E). The radius of the arc is 36 Å, and the longest di-
mension is 115 Å. The FANCA CTD structure consists
of a chimera of 14 HEAT repeats and three helical mo-
tifs (HMs) with two to four helices. The FANCA CTD
can be divided into three subdomains (Figure 1D and E;
Supplementary Figure S3); the N-terminal helical subdo-
main inside the arc (residues 530–619, cyan), the N-terminal
half (arcN, residues 632–900, FANCA in light orange and
FANCA’ in light green) and C-terminal half (arcC, 901–
1403, FANCA in orange and FANCA’ in green) of the
arc-shaped CTD (Figure 1D and E). The helical subdo-
main which is visible only in FANCA’ is packed against
the arcC subdomain and is connected to the HEAT 3 re-
peat through the linker helix. The loop between the linker
helix and the H3A helix is disordered, suggesting that this
region can undergo dynamic movement. Although the two
FANCA CTD molecules share similar structures, one of
them (FANCA CTD, orange) is slightly more open than the
other (FANCA’ CTD, green), with a root mean square de-
viation (rmsd) value of 2.2 Å when all C atoms of the arc
domains are aligned (Supplementary Figure S5). The loops
connecting the helices within a repeat (intra-repeat loops) as
well as adjacent repeats (inter-repeat loops) vary in length
and conformation, resulting in the formation of surfaces
where another CTD or NTD of FANCA or FANCG binds.
Pseudo-symmetric dimeric interface between the two
FANCA CTD molecules
The convex surface forms a wide and shallow groove (44 Å
width, 35 Å length, 6 Å depth), through which the exten-
sive dimer interface (6238 Å2) is created. The two FANCA
CTDs interact in a head-to-tail manner, in which the arcC
subdomain of FANCA’ CTD (green) interacts with the
arcN subdomain of FANCA CTD (orange; Figures 1E and
2A). The dimeric interface between the two FANCA CTD
molecules includes an extended network of interactions in-
volving more than 40 H-bonds, 10 ion-pairs and extensive
hydrophobic and van der Waals contacts.
At the center of the dimer, two parallel H8B helices
run along the 2-fold rotation axis (Figure 2A and B).
Two Cys pairs (C999-C999 and C1006-C1006) are in close
proximity, consistent with the results of the intermolecu-
lar crosslinking analysis using hydrogen peroxide and bis-
maleimidoethane (Figure 2B and Supplementary Figure
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Figure 2. The dimer interface of FANCA. (A) View looking down the dimer interface between the arcC of FANCA CTD (orange) and the arcN of FANCA’
CTD (green). Boxes contain clusters of contacts with their respective segments labeled. (B) Close-up view of the central interface in box b from (A). A view
is orthogonal to the projection in (A). Black dotted lines indicate polar interactions. The interface is formed by the interactions between the H8B and the
H8B’ helices and between the H8B’ and the H10B helices. (C) Close-up view of the interface between the H7B’ helix from FANCA’ CTD and the H9B,
H10B and HM2C from FANCA CTD. A view is orthogonal to the projection in (A). The interface is formed primarily by the hydrogen bonds and polar
interactions between the main chain and side chain. (D) Close-up view of the interface between the arch’ loop and the H11A and H12A helices in the same
projection of (A).
and one ion pair (Asp928-Arg1053) further stabilize this
interface, which extends continuously in both directions.
On the right side of the center, H7B’ from FANCA’ CTD
forms another interface with three helices (H9B, H10B and
HM2C) from FANCA CTD (Figure 2A and C). Polar in-
teractions (eight H-bonds and an ion pair) dominate this in-
terface. A third interface is formed between the arch’ loop
of FANCA’ CTD and H11A and H12A near the end of
FANCA CTD (Figure 2D). However, these interactions are
not formed at the reciprocal end, exhibiting the pseudo-
symmetrical nature of a CTD dimer.
Many residues at the interface between the CTD dimer
are mutated in FA- patients and cancer cells (Supplemen-
tary Figure S3), pointing to the significance of the dimeriza-
tion. A double mutation of Leu1069 and Leu1076 (Leu1042
and Leu1048 in Xl FANCA) to Ala disrupted dimerization
and abrogated the SSA activity of FANCA (28). Leu1048
is packed against Leu1029, Leu1049 and Cys1051 near the
dimeric interface (Supplementary Figure S6A). Arg951Trp
(Arg931 in Xl FANCA) and Gln1128Glu (Tyr1100) mu-
tations decreased SSA activity by 40% (28). These two
residues are near the dimeric interface. Arg931 forms an ion
pair with Asp996, which is near Ser990 of another CTD
molecule (Supplementary Figure S6B), while Tyr1100 is
packed against Gln1148 and Leu1149, and within 4 Å from
Asn940 of an adjacent CTD molecule (Figure 2C and Sup-
plementary Figure S6C). Thus, many residues mutated in
FA patients are at the dimeric interface and tightly corre-
lated with SSA and SSE activities, confirming the impor-
tance of FANCA dimerization for these activities.
Arg1117 is mutated to glycine in a cancer cell line and
the mutation of this residue decreases SSA activity of
FANCA (28, Supplementary Figure S3). The correspond-
ing residue Lys1089 in Xl FANCA is located near the sur-
face. We predict that this residue might interact with ss-
DNA (Figure 3). Around this site, a narrow groove is
formed by the H7B helix, the H8A-H8B loop, the HM3B
helix and the C-term loop, through which ssDNA can pass
(Figure 3B). Positively charged residues Lys1167, Lys1086,
Arg1294, Lys1044, Lys920 and Lys1248 pave the groove
along Lys1089 in FANCA CTD (Figure 3A). In addi-
tion, the positively charged groove extends continuously to
FANCA’ CTD in which Lys1248, Lys989 and Lys920 dec-
orate the positively charged surface. We speculate that the
two ssDNA molecules bind to these surface grooves in close
proximity in the CTD dimer, providing the basis for the
SSA and SSE activities. Importantly, it is also possible that
FANCA anchors the core complex near ICLs on chromatin
through binding ssDNA regions at stalled replication forks
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Figure 3. A putative ssDNA binding path in the FANCA CTD dimer. (A) Two views of the structure of the FANCA CTD dimer with positively charged
residues in space-filling model. (B) Surface representation of the FANCA CTD dimer with electrostatic potential in two different views. The electrostatic
potential was calculated with Adaptive Poisson-Boltzmann Solver (APBS) and illustrated (–6 to +6 kT) with PyMOL. The positive potential is shown in
blue and the negative potential is shown in red. A putative ssDNA binding path is shown in a yellow dotted line. Orientations of the structures are same
as those in (A).
Structural basis for the functional defects of patient-derived
FANCA mutations
FA- and cancer-associated mutations are dispersed over the
entire -solenoid rather than clustered within a localized re-
gion. A number of the mutated residues are buried in the
interior of the FANCA CTD, indicating that pathogenic ef-
fects can result from structural defects in the affected pro-
teins (Figure 4 and Supplementary Figure S6). FANCA mu-
tations lead to mild, intermediate, or severe FA-associated
phenotypes (40). In severe FA phenotypes, FANCA mu-
tants fail to interact with FANCC and FANCF, are local-
ized to the cytoplasm, and are unable to monoubiquitinate
FANCD2, yet they remain associated with FANCG. Many
of the residues that are mutated in severe cases are found to
be buried in the core of FANCA, while some are exposed on
the surface. For example, Trp1274 (Trp1302Arg mutation
in human FANCA) is surrounded by Phe1278, Val1275,
Leu1315 and Val1320, and mutation of this residue is
predicted to destabilize the local structure (Figure 4B).
Arg1028 (the Arg1055Trp mutation in human FANCA) is
buried and forms an ion pair with Glu965 in the middle of
the arc, and FANCA harboring this mutation fails to be
imported into the nucleus (Figures 4C and 5C). However,
Gln1082 (the His1110Pro mutation in human FANCA) is
exposed at the surface, and it is unlikely that mutation
of this residue disrupts the local structure (Supplementary
Figure S6D). Nevertheless, mutation of this residue affected
interactions with FANCF and FANCC, and the complex
failed to localize at the nucleus (40). Thus, Gln1082 is likely
to be directly involved in the interaction with other FANC
core members.
In addition to point mutations, deletion mutations are
also observed in FA patients and several deleted residues
are located at the dimeric surface. Deletion of FANCA-
Phe1135 or Trp1174 is observed in several FA patients
(41,42). Phe1107 (Phe1135 in human FANCA) at the H10B
helix of FANCA CTD is located in a hydrophobic envi-
ronment, packed against the H7B’ helix of FANCA’ CTD
(41, Supplementary Figure S6C). Trp1146 (Trp1174 in hu-
man FANCA) is at the HM2B-HM2C of FANCA’ CTD,
packed against Leu1149, Leu1169, Leu1172 and Arg1173
(42).
Another class of mutants exhibit partially abolished in-
teractions with FANCC or FANCF, moderate nuclear lo-
calization, and mild ubiquitination of FANCD2 (40). These
mutants include Met1333 (the Met1360Ile mutation in hu-
man FANCA) and Tyr796 (the Leu817Pro mutation in
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Figure 4. Structure of the selected missense mutations of FANCA from the Fanconi Anemia Mutation Database (http://www2.rockefeller.edu/fanconi/)
and Catalogue of Somatic Mutations in Cancer (https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=FANCA). (A) An overall structure of the FANCA
CTD complexed with the FANCG CTD (purple). The selected FA- and cancer-associated mutations are illustrated in space filling model. FANCA CTD
(green) is shown in surface representation. FANCG is packed against the C-terminal end of a FANCA CTD molecule. (B) A mutated residue analyzed in
the present study is shown in yellow color. Trp1274 (Trp1302Arg mutation in human FANCA). (C) Arg1028 (Arg1055Trp). (D) Met1333 (Met1360Ile).
(E) Phe1236 (Phe1262Leu) and Phe1237 are patient-derived missense and deletion mutation, respectively. (F) Leu1055 (Leu1082Pro).
residues Phe1308, Met1280, Phe1278 and Ile1329 (Figure
4D). Tyr796 is packed against Met750, Leu747, Leu751,
Leu800, Leu793 and Trp797 (Supplementary Figure S6E).
The third class of FA- and cancer-associated mutants
have no interaction defects with other FANC proteins,
and do not exhibit abnormalities in nuclear trafficking or
FANCD2 ubiquitination (40). Tyr1100 (the Gln1128Glu
mutation in human FANCA) at the dimeric interface be-
longs to this class (Figure 2C and Supplementary Figure
S6C). Thus, disruption of the dimeric interface may not
affect binding to the FANC core protein or nuclear traf-
ficking, consistent with the observation described above.
Phe1236 (the Phe1262Leu mutation in human FANCA)
also belongs to this class. We tested the cellular localiza-
tion of the Phe1262Leu protein by transiently expressing
WT and mutant FANCA protein in U2OS cells and im-
munostaining after treatment with the crosslinking agent
MMC. While the FANCA-WT located to the nucleus as
expected, FANCA- Phe1262Leu mutation was localized in
cytoplasm in our analyses, consistent with our structural
analysis but in contrast to reported data (Figure 5C and
Supplementary Table S2). Phe1236 is buried in a hydropho-
bic environment surrounded by Leu1277, Leu1292, Ile1140
and Met1240, hence its mutation is expected to destabilize
the local structure (Figure 4E). We predict that this mu-
tant would exhibit a severe FA phenotype. Mutation of the
neighboring Phe1237 residue (delF1263) abrogated the in-
teraction with FANCC and FANCF, and consistent with
this observation belongs to the class exhibiting severe phe-
notype (Figure 4E).
Interface between FANCA CTD and FANCG CTD is critical
for the nuclear import of FANCA
In one class of FANCA and FANCG complex structures,
we observed EM density for a twisted helical molecule near
the C-terminal end of FANCA. The molecule folds into
an extended -solenoid structure (longest axis with 190
Å) with multiple TPR motifs, and was predicted to cor-
respond to FANCG (43,44). To confirm our prediction,
we performed a yeast two-hybrid analysis (Supplementary
Figure S7A). We first examined whether FANCG interacts
with the CTD of FANCA. In all conditions tested, FANCA
CTD unambiguously interacts with the CTD of FANCG.
Crosslinking mass spectrometry analysis showed that the
CTD of FANCG recognizes the C-terminal end of FANCA
(15). Deletion of the C-terminal 37 residues of FANCG re-
sulted in strong reduction in binding to FANCA (45). Thus,
based on all available information, we conclude that the
molecule corresponding to the EM density is FANCG. We
observed EM density for half of the full-length FANCG
(319 residues out of 640 residues), and the resolution did
not allow us to assign the side-chains. However, the reported
biochemical studies (46) and our data described in the next
paragraph suggest that the structure corresponds to the C-
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Figure 5. Interactions between FANCA CTD mutants and FANCG CTD and their mutational effects in nuclear localization of FANCA (A) Yeast two
hybrid analyses between deletion mutants of FANCA CTD and FANCG CTD. Master plate (SD-LeuTrp) and a selective plate (SD-LeuTrpHis containing
10 mM of 3-AT) are shown on the left and right, respectively. (B) Yeast two hybrid analyses between FANCA CTD with selected point mutants and
FANCG CTD. Master plate (SD-LeuTrp) and a selective plate (SD-LeuTrpHis containing 10 mM of 3-AT) are shown on the left and right, respectively.
Structures of the point mutants are shown in Figure 4. (C) FANCA-knockout U2OS cells expressing indicated mutants in the presence of 1uM MMC were
immunostained to visualize FANCA. Cell nuclei were detected with 4′,6-diamidino-2-phenylindole (DAPI).
The C-terminal helices (HEAT13 and HEAT14) of the
arcc subdomain are packed against the terminal TPR mo-
tifs of FANCG that fold into a superhelical structure (Fig-
ures 1B and 4A). The convex surface of FANCG forms a
shallow groove with three helices from three TPR repeats
at the C-terminal end. These helices are packed against the
H13 and H14 repeats of FANCA. To confirm our proposed
structure, we deleted residues 1374–1455 or residues 1410–
1455 at the C-terminal end of FANCA and examined bind-
ing to FANCG using yeast-two hybrid analyses. Both dele-
tion mutations significantly decreased binding to FANCA
CTD (Figure 5A). In line with this observation, we found
that expression of the C-terminal deleted FANCA protein
(residues 1–1373 or residues 1–1409) in U2OS yielded ex-
clusively cytoplasmic protein, suggesting that the interface
between FANCA CTD and FANCG CTD is important for
the nuclear import of FANCA (Figure 5C and Supplemen-
tary Table S2).
To explore the significance of this interface in FA and
cancer, we mutated five residues of FANCA observed
in FA-patients or cancer cells, and examined binding
between FANCA CTD and FANCG using yeast two-
hybrid analyses. These included Arg1055Trp (Arg1028 in Xl
FANCA), Leu1082Pro (Leu1055), Phe1262Leu (Phe1236),
Trp1302Arg (Trp1274) and Met1360Ile (Met1333). All
five FA disease-associated mutants failed to interact with
FANCG through their CTDs (Figure 5B). Thus, the
residues mutated in these mutants are expected to destabi-
lize the local structure of FANCA. As we observed for the
C-terminal deletion mutant of FANCA, expression of all of
these five mutants in U2OS cells resulted primarily in cyto-
plasmic protein in the absence or presence of MMC, con-
sistent with the need for an intact FANCA–FANCG inter-
action for nuclear transport (Figure 5C and Supplementary
Table S2). We conclude that destabilization of the interface
between FANCA CTD and FANCG CTD prevents local-
ization of FANCA in the nucleus.
FANCA recognizes FANCG through its NTD
Dimerization of the two FANCA protomers creates contin-
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FANCA CTD protrude into the middle of this inner sur-
face, forming a deep groove together with arcN subdomains
from both FANCA protomers (Figure 6A). The fourth class
of structures reveals EM density for an unknown molecule
that occupies the groove as well as extensive inner surface of
FANCA CTD (Figure 6B). The elongated shaped EM den-
sity is formed entirely with helices and with dimensions of
28 × 38 × 93 Å3. This unknown molecule could be either
FANCG or the NTD of FANCA. We modeled 16 helices
onto this density (Figure 6B). However, due to ambiguity,
we did not assign side chains in this molecule. The molecule
folds into multiple HEAT repeats and contains 310 residues.
The molecule interacts with both FANCA and FANCA’.
While the groove formed by the U loop and the H5A and
the H6A helices from FANCA and the H5A’-H5B’ loop
from FANCA’ are mainly involved in the binding to the un-
known molecule, the H3A’, H4A’ and H5A’ helices and the
H7A’-H7B’ loop from FANCA’ also contribute to the bind-
ing (Figure 6C). Thus, both FANCA protomers appear to
be important in the recognition of the unknown molecule.
The unknown molecule adopts a significantly different
structure from that of FANCG, although we only know
the C-terminal half of the FANCG structure. Because
the molecule is docked at the concave surface formed by
the FANCA and FANCA’ dimer, we hypothesized that
the disruption of the FANCA dimeric interface is likely
to affect the binding of the molecule to FANCA CTD.
We thus generated mutants at or near the dimeric in-
terface of FANCA to examine the effects of the muta-
tion on the binding of FANCG. Specifically, we gener-
ated Arg1136Gly (Arg1108 in Xl FANCA) mutant, and
deleted the U loop spanning Tyr996 to Phe1008 at the
concave surface to disrupt the dimeric interface (Figure
2B and C). We also made a Leu1069Ala/Leu1076Ala
(Leu1042/Leu1048) double mutant. Previous study showed
that the Leu1069Ala/Leu1076Ala mutation dissociates the
FANCA dimer into a monomer (28). None of the mu-
tants targeted at the dimeric interface or at the groove af-
fected the interaction between FANCG and FANCA CTD
(Figure 5B and Supplementary Figure S7). In addition, we
disrupted the groove by introducing Ser1019Arg(Cys999)
or Ala1026Arg(Cys1006) mutation at the dimeric inter-
face (Figure 2B). We observed normal interaction between
FANCG and these FANCA CTD mutants (Supplemen-
tary Figure S7). Crosslinking mass spectrometry analyses
revealed a number of intramolecular interactions with the
NTD of FANCA in this region (15), supporting our con-
clusion that the molecule is the NTD of FANCA.
The four helices and the two loops at the C-terminal
part of the NTD interact with the CTD dimer. Only the
NTD and the helical subdomain of FANCA’, but not that
of FANCA is observed inside the arc dimer, suggests that
this region of FANCA is flexible and undergoes dynamic
rigid body movement. At the N-terminus of NTD, we ob-
served a bulky EM density, which cannot be clearly re-
solved. The overall shape of FANCG -solenoid well agrees
with this EM density. Previous binding analyses from dif-
ferent groups suggest that the 250 residues of FANCA in-
teract with a region containing 400–475 or the N-terminal
428 residues of FANCG (45,46). The NLS motif containing
residues 19–28 of FANCA are critical in this interaction.
Our structure shows that the N-terminal region of FANCA
binds near the middle rather than the either end of FANCG,
consistent with the reported data. The low resolution den-
sity for FANCG and the N-terminus of FANCA clearly in-
dicate the dynamic nature of this region in the complex.
The structure of the FANCA–FANCG hetero-tetramer com-
plex
Although we observed the two different structures of the
FANCA and FANCG complex, in which a FANCA ho-
modimer binds to a FANCG protomer at different sites in
a 2:1 stoichiometry, the size exclusion analysis showed that
FANCA and FANCG forms a 2:2 complex (Supplemen-
tary Figure S1). We therefore constructed a model of the
hetero-tetramer structure by aligning the FANCA dimer of
one AG complex (Figure 1B) onto FANCA’ of another A’G’
complex (Figure 1C). The hetero-tetramer structure forms
a curved G-A-A’-G’ chain shape, in which one FANCG
molecule is positioned at the end of the NTD of FANCA
and another one at the end of FANCA’ CTD, separating
the two FANCG protomers by ∼130 Å (Figure 7A). The
NTD of FANCA is visible only in one FANCA structure.
However, it is possible that the NTD of both FANCA pro-
tomers could be visible in the presence of other FANC core
components.
The NTD of FANCA undergoes highly dynamic rigid
body movement, and the FANCA CTD forms a head to
tail dimer. Therefore, in this geometry, it is possible that
the two FANCG protomers bind to both ends of one
FANCA, in principle, which suggests that the two FANCA
protomers can recruit four FANCG protomers. Although
we do not completely exclude a possibility that a complex
may be formed with different stoichiometry, the hetero-
tetramer complex is most consistent with the biochemical
data. Furthermore, the presence of other FANC core com-
ponents may restrict the movement of FANCG and the
NTD of FANCA, and thus the stoichiometry of FANCA
and FANCG is likely to be limited to 2:2 in the complete
core complex. We note that the structure of human FANC
core complex containing FANCA and FANCG is reported
while this work is under review (47). The structure also re-
ports the two binding modes for FANCA and FANCG in
a 2:2 complex––one between FANCA NTD and FANCG
and the other between FANCA CTD and FANCG CTD,
which supports the present study.
Putative FAAP20-binding interface within FANCA
FAAP20 binds directly to FANCA and increases its sta-
bility (48–51). In the absence of FAAP20, FANCA is ex-
posed and undergoes SUMO-dependent proteolytic degra-
dation, leading to loss of integrity for the FA core complex
(52). Mutations that disrupt the binding of FAAP20 ex-
hibit a mild phenotype. Sumoylation occurs at Lys921 (loop
HM1C-H7A), equivalent to Arg901 in Xl FANCA (Supple-
mentary Figure S8). The exposed Lys903 close to Arg901
is a good candidate for sumoylation. Ile939Ser (Leu919 in
Xl FANCA) mutation of FANCA exhibits a separation-
of-function phenotype since the mutant can assemble the
FANCA core complex and monoubiquitinate the ID com-
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Figure 6. Structure of the FANCA’ complexed with FANCG’ through its NTD. (A) The NTD (yellow) of FANCA’ is docked into the inner surface of its
CTD dimer. The deep groove is formed at the middle of the inner surface, in which the FANCA’ NTD is lodged. The opposite end of the NTD interacts
with FANCG’ (purple). (B) The EM density for the NTD of FANCA’. The NTD consists of multiple HEAT repeats. (C) Close-up view of the interface
between FANCA’ NTD and the CTD dimer. Side chains from the two CTD protomers are shown.
synthesis (TLS) polymerization. Leu919 is partly buried
in a hydrophobic environment surrounded by Trp915 and
Phe970, and 25 Å distant from Lys903. We predict that
the mutation of Leu939 to serine likely leads to local
structural perturbation (Supplementary Figure S8). One
FAAP20 protomer could interact with one FANCA pro-
tomer in the AG20 subcomplex, but other FANC core com-
ponents might affect the stoichiometry between FANCA
and FAAP20 in the full FANC core complex.
DISCUSSION
Over 90% of patient-derived point-mutations in FANCA
correspond to residues in the CTD (29). Nevertheless, the
structure and function of the FANCA CTD remain poorly
understood. In this study, we explore the role of the FANCA
CTD in the FA pathway, and provide structural insight
into disease-associated FANCA mutations. We present two
different structures of the FANCA–FANCG complex as
well as structures of FANCA alone. The combined anal-
ysis of these two complex structures suggest that two dif-
ferent FANCG protomers bind to two FANCA protomers
forming a FANCG–FANCA–FANCA–FANCG hetero-
tetramer.
The structures of the FANCA and FANCG complex re-
veal two important features of the FANCA CTD that ex-
plain why it is critical for the function of FANCA and the
FANC core complex. The first feature is dimerization of
FANCA CTD, which, in addition to a possible role in FA
core complex formation, has been suggested to be impor-
tant for the reported SSA and SSE activities of FANCA
(9,12,28). The structure reveals a possible path through
which the ssDNA molecule interacts. A long shallow groove
is decorated with over 15 positively charged residues in each
CTD arc. The groove starts from Lys1167 and Arg1294 at
one end and extends to Arg748 at the other end (Figure 3).
The distance between the two ends is near 70 Å, indicating
that a long ssDNA molecule is required for binding, con-
sistent with the DNA binding analyses. Near the dimeric
interface, this groove is connected to the path generated by
another FANCA CTD molecule. The grooves from the two
FANCA CTDs may therefore locate part of the two ssDNA
molecules in close proximity, thereby promoting the SSA
activity with the help of FANCA bound to FANCG. While
the FANCA CTD dimer provides a binding platform for the
two ssDNA molecules, the FANCA NTD complexed with
FANCG is required for both SSA and SSE activities (28).
Although the mechanism remains unknown, we speculate
that dynamic movement of the FANCA NTD complexed
with FANCG might increase the chance of the two ssDNA
strands encountering each other. Although not yet exper-
imentally explored, the same DNA binding site may also
play a role in anchoring FANCA and the core complex on
the DNA at stalled replication forks. Because the AG com-
plex contributes to the recruitment of the BL100 complex
to the damages sites or chromatin independent of the CEF
complex, anchoring of FANCA on the DNA could be crit-
ical for the function of FANC core complex (6).
Many FANCA mutations prevent the localization of the
protein to the nucleus and cell expressing these mutant
FANCA protein are unable to form a nuclear FA core com-
plex. It is unclear if dimerization occurs in the cytosol and is
required for FANCA nuclear import. FANCA forms vari-
ous complexes in the cell; a 0.5 MDa complex in the cy-
tosol, a 2 MDa complex in the nucleus and a 1 MDa com-
plex on chromatin (53). A double mutant L1069A/L1076A
that forms a FANCA monomer is efficiently transported
into the nucleus (28, Figure 5C). Thus, mutations that af-
fect the dimerization might not be critical for the nuclear
localization of FANCA.
Crosslinking mass spectrometry data showed that
FANCA interacts with a number of other FANC core
proteins including FANCG (15). This network suggests
that FANCA undergoes dynamic assembly with other
FANC core members. The two different structures of
the FANCA and FANCG complexes observed here sup-
port the dynamic assembly of FANCA. The observed
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Figure 7. The two interfaces between the FANCA and FANCG complex are required for nuclear transport of FANCA. (A) Structure of the FANCA–
FANCG hetero-tetramer complex in two different views. The structure was reconstituted by aligning a FANCA CTD dimer of one FANCA–FANCG
complex onto that of another complex. The EM map for the two FANCG molecules are shown in gray color. FANCA binds to the FANCG CTD via its
C-terminal helical repeats and FANCA’ binds to FANCG’ through its NTD. (B) A cartoon representing a model by which disruption of either one of the
two interfaces prevents the localization of FANCA into the nucleus.
expected because different groups reported that the NLS
of the FANCA NTD is recognized by FANCG (21,24).
Deletion of the bipartite NLS motifs either impeded or
completely blocked the nuclear localization of FANCA
(24,45,54). Two regions of FANCG are involved in the
complex formation with FANCA (45). Residues 400–475
are necessary for the binding of FANCG with FANCA
and the C-terminal 37 residues (residues 585–622) aug-
ment the binding. Due to the limited resolution of the
structure for the FANCA NTD and FANCG complex,
we were unable to map this interface in atomic detail
(Figure 1C). However, the structure suggests that the
binding for the N-terminal region of FANCA occurs near
the middle region rather than the C-terminal region of
FANCA. By contrast, FANCA binding to the FANCG
CTD occurring via its helical repeats at the C-terminal
end was unexpected. Yeast two-hybrid and crosslinking
mass spectrometry analyses confirmed the presence of this
interface (15) (Supplementary Figure S7A). Deletion of
the C-terminal 37 residues or the two C-terminal helices of
FANCA strongly reduced or abrogated the interaction with
FANCG, respectively, demonstrating the significance of the
interface (45) (Figure 5A). In previous analyses, FA-patient
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interaction between FANCA and FANCG (40). Because
FANCA binds to FANCG through two distant interfaces
(FANCA’ NTD-FANCG’ and FANCA CTD-FANCG
CTD), mutations that disrupt one interface are unlikely to
affect the other interface, and FANCA still could form a
complex with FANCG. Thus, binding of FANCA mutants
to FANCG might not reflect all interactions between the
two proteins. The five mutants that failed to interact with
FANCG through their CTDs were not transported into the
nucleus in our analysis (Figure 5B and C; Supplementary
Table S2). Thus, we propose that the interaction between
FANCA CTD and FANCG CTD is important for nuclear
localization. This explains why FANCA mutants lacking
the CTD region were able to form a complex with FANCG,
but failed to translocate into the nucleus (24).
Overexpression of a FANCA mutant lacking the C-
terminal region (residues 1–1200) or the N-terminal 28
residues induced hypersensitivity to MMC (45). Our stud-
ies suggest that these results are due to the impaired nuclear
localization, emphasizing the importance of the FANCA–
FANCG complex formation in nuclear transport of these
proteins. FANCG might interact with importin- and func-
tion as an adaptor that mediates the transport of FANCA
and other FANC core proteins into the nucleus. Yeast two-
hybrid screening identified several candidate proteins that
interact with FANCA (55). A set of these proteins are clas-
sified as transporters. These include NTF97 (importin beta
subunit 97 nuclear transport factor), Sorting nexin 5 and
9 (56), and Kinectin. Alternatively, FANCG itself might
function as an importin. Nucleoporin 155 (nuclear pore
complex) and Nucleoporin p62, nuclear pore complex di-
rectly associated with FANCA in Yeast two-hybrid analy-
ses. Deletion of C-terminal residues of FANCG did not af-
fect the localization of FANCG (46). In our analysis, this
is the region that interacts with the C-terminal region of
FANCA. Thus, it is possible that FANCG can be translo-
cated to the nucleus independently of FANCA, whereas
the nuclear localization of FANCA depends on FANCG.
Understanding how the interaction between FANCA CTD
and FANCG CTD facilitates nuclear localization requires
further investigation.
Although the FANCA–FANCG complex formation via
two interfaces is important for nuclear localization of
FANCA, forced nuclear targeting of FANCA (residues 29-
1455) with SV40 NLS failed to rescue its complementation
function (45). This suggests that the formation of the in-
tact G-A-A’-G’ hetero-tetramer structure is not only im-
portant for the nuclear transport of FANCA, but also re-
quired for the ID monoubiquitination by the FANC core
complex. The NTD and the helical subdomain is observed
only in one of the FANCA protomers, suggesting that
each NTD undergoes significant dynamic motion, which
makes FANCA an asymmetric dimer with two different
binding sites for FANCG. The asymmetric structure of the
FANCA–FANCG hetero-tetramer is compatible with the
recently reported FANC core structures with an asymmet-
ric architecture (15,47) In these structures, the FANC core
complex is assembled with two BL100 subcomplexes and
one CEF complex (PDB ID: 6SRI, see our model in Sup-
plementary Figure S9). The symmetry of the two BL100
hetero-trimers at the center is disrupted by the binding of
the CEF substrate-binding module to one side of the two
BL100 subcomplexes, which induces a change in orientation
in one of the BL100 subcomplexes and prevents the dock-
ing of a second CEF on the other side (15,47). Importantly,
FANCL in each side of the core complex forms a differ-
ent conformation, orientation, and packing against nearby
components in such a way that only one side of the complex
can accommodate the ID substrate, whereas the other side
forms an inactive state (15). The structure from Wang et al.
suggests that only asymmetric FANCA–FANCG hetero-
tetramer complex with two different binding modes sim-
ilar to our structure but not the symmetric complex fits
into the two different sides of the FANC core complex (47).
Therefore, the asymmetrical G-A-A’-G’ architecture of the
FANCA–FANCG complex presented in this study plays an
important role in creating the FANCL conformation to ac-
commodate the ID complex only in one side of the complex,
thereby monoubiquitinates the ID complex.
The FANCA and FANCG complex structure provides
insight into disease-associated FANCA mutations. Several
FA- and cancer-associated mutants involve residues at or
near the dimeric interface. Most of the mutants at the
dimeric interface exhibit significantly decreased SSA or SSE
activities, and some of retain normal ID ubiquitination ac-
tivity (28). Thus, a class of disease-associated mutants that
do not or only mildly disrupt the structure at or near the
dimeric interface is likely to be associated with defects in
these (SSE or SSA) activities, as proposed previously by
Zhang’s group (28). By contrast, the mutation of buried
residues is likely to disrupt the partial or full structure of
FANCA in the FA-patients. All five mutants tested herein
that belong to this class failed to be imported into the nu-
cleus, which may be largely due to defective interaction with
FANCG, but association with other cellular proteins might
also contribute to this process.
With only limited biochemical and cellular data available
for disease-associated mutants, it is difficult to draw gen-
eral conclusions pertinent to all patient-derived mutations
at present. However, the structure of FANCA coupled with
future experimental data on a wider range of FANCA mu-
tants should shed light on FA- and cancer-associated muta-
tions.
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